Categories
- Global News Feed
- Uncategorized
- Alabama Stem Cells
- Alaska Stem Cells
- Arkansas Stem Cells
- Arizona Stem Cells
- California Stem Cells
- Colorado Stem Cells
- Connecticut Stem Cells
- Delaware Stem Cells
- Florida Stem Cells
- Georgia Stem Cells
- Hawaii Stem Cells
- Idaho Stem Cells
- Illinois Stem Cells
- Indiana Stem Cells
- Iowa Stem Cells
- Kansas Stem Cells
- Kentucky Stem Cells
- Louisiana Stem Cells
- Maine Stem Cells
- Maryland Stem Cells
- Massachusetts Stem Cells
- Michigan Stem Cells
- Minnesota Stem Cells
- Mississippi Stem Cells
- Missouri Stem Cells
- Montana Stem Cells
- Nebraska Stem Cells
- New Hampshire Stem Cells
- New Jersey Stem Cells
- New Mexico Stem Cells
- New York Stem Cells
- Nevada Stem Cells
- North Carolina Stem Cells
- North Dakota Stem Cells
- Oklahoma Stem Cells
- Ohio Stem Cells
- Oregon Stem Cells
- Pennsylvania Stem Cells
- Rhode Island Stem Cells
- South Carolina Stem Cells
- South Dakota Stem Cells
- Tennessee Stem Cells
- Texas Stem Cells
- Utah Stem Cells
- Vermont Stem Cells
- Virginia Stem Cells
- Washington Stem Cells
- West Virginia Stem Cells
- Wisconsin Stem Cells
- Wyoming Stem Cells
- Biotechnology
- Cell Medicine
- Cell Therapy
- Diabetes
- Epigenetics
- Gene therapy
- Genetics
- Genetic Engineering
- Genetic medicine
- HCG Diet
- Hormone Replacement Therapy
- Human Genetics
- Integrative Medicine
- Molecular Genetics
- Molecular Medicine
- Nano medicine
- Preventative Medicine
- Regenerative Medicine
- Stem Cells
- Stell Cell Genetics
- Stem Cell Research
- Stem Cell Treatments
- Stem Cell Therapy
- Stem Cell Videos
- Testosterone Replacement Therapy
- Testosterone Shots
- Transhumanism
- Transhumanist
Archives
Recommended Sites
Category Archives: Global News Feed
Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2022
Posted: May 15, 2022 at 2:13 am
Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2022.
Read the original:
Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2022
Posted in Global News Feed
Comments Off on Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2022
The Greenrose Holding Company to Hold First Quarter 2022 Conference Call on May 16, 2022 at 5:30 p.m. ET
Posted: May 15, 2022 at 2:13 am
AMITYVILLE, N.Y., May 13, 2022 (GLOBE NEWSWIRE) -- The Greenrose Holding Company Inc. (OTC: GNRS, GNRSW) (“Greenrose” or the “Company”), a multi-state grower and producer of cannabis brands and products, will hold a conference call on Monday, May 16, 2022 at 5:30 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2022. The Company will provide its financial results in a press release prior to the conference call.
Continued here:
The Greenrose Holding Company to Hold First Quarter 2022 Conference Call on May 16, 2022 at 5:30 p.m. ET
Posted in Global News Feed
Comments Off on The Greenrose Holding Company to Hold First Quarter 2022 Conference Call on May 16, 2022 at 5:30 p.m. ET
Blue Water Vaccines Reports First Quarter 2022 Financial Results and Recent Business Developments
Posted: May 15, 2022 at 2:13 am
CINCINNATI, May 13, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), today announced its financial results for the first quarter ended March 31, 2022 and provided an update on recent business developments and progress. Blue Water Vaccines is a pre-clinical stage biotechnology company developing vaccines against multiple infectious diseases, including influenza, norovirus, rotavirus, and acute otitis media (AOM) from Streptococcus pneumoniae colonization.
Go here to see the original:
Blue Water Vaccines Reports First Quarter 2022 Financial Results and Recent Business Developments
Posted in Global News Feed
Comments Off on Blue Water Vaccines Reports First Quarter 2022 Financial Results and Recent Business Developments
Zosano Pharma Reports First Quarter 2022 Financial Results
Posted: May 15, 2022 at 2:13 am
FREMONT, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2022. All share and per share information included in these financial results and statements has been retroactively adjusted to give effect to our April 11, 2022 1-for-35 reverse stock split.
Go here to read the rest:
Zosano Pharma Reports First Quarter 2022 Financial Results
Posted in Global News Feed
Comments Off on Zosano Pharma Reports First Quarter 2022 Financial Results
Calliditas Therapeutics Launches an Online Patient Platform
Posted: May 15, 2022 at 2:13 am
This launch coincides with the inaugural IgAN Awareness Day This launch coincides with the inaugural IgAN Awareness Day
Read the original:
Calliditas Therapeutics Launches an Online Patient Platform
Posted in Global News Feed
Comments Off on Calliditas Therapeutics Launches an Online Patient Platform
Zosano Pharma Provides Corporate Update
Posted: May 2, 2022 at 2:43 am
FREMONT, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today provided a corporate update.
See the article here:
Zosano Pharma Provides Corporate Update
Posted in Global News Feed
Comments Off on Zosano Pharma Provides Corporate Update
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies…
Posted: May 2, 2022 at 2:43 am
COPENHAGEN, Denmark, April 29, 2022 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.
Posted in Global News Feed
Comments Off on Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies…
Dividend approval
Posted: May 2, 2022 at 2:43 am
Press release
Here is the original post:
Dividend approval
Posted in Global News Feed
Comments Off on Dividend approval
Kane Biotech Announces Extension of Private Placement Offering
Posted: May 2, 2022 at 2:43 am
Not for distribution to U.S. news wire services or dissemination in the United States
The rest is here:
Kane Biotech Announces Extension of Private Placement Offering
Posted in Global News Feed
Comments Off on Kane Biotech Announces Extension of Private Placement Offering
CORRECTION – Coherus BioSciences to Report First Quarter 2022 Financial Results on May 5th, 2022
Posted: May 2, 2022 at 2:43 am
REDWOOD CITY, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Coherus BioSciences, Inc. (Nasdaq: CHRS), please note in the Conference Call Information, the start time should be 4:30 p.m. ET, not 5 p.m. ET as previously stated. The corrected release follows:
The rest is here:
CORRECTION - Coherus BioSciences to Report First Quarter 2022 Financial Results on May 5th, 2022
Posted in Global News Feed
Comments Off on CORRECTION – Coherus BioSciences to Report First Quarter 2022 Financial Results on May 5th, 2022